John Schroer

TCW maintains a value-oriented investment approach and their investment process focuses on preserving capital for their clients. The firm’s integrated top-down and bottom-up investment process emphasizes global and multi-sector diversification to generate attractive risk-adjusted returns from income and capital appreciation. They offer a range of investment strategies across fixed income, equities, and emerging markets.

Part of Invesco Ltd., INVESCO Funds Group, Inc. is a company based in Denver, CO.

Itros manages a long/short equity hedge fund focused on the health care sector.

HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services.

Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein

Functions as a College/University

AGI is an active manager which conducts in-house proprietary research to invest in public equity and fixed-income markets globally. The firm offers a range of investment strategies and styles. They make equity investments in value and growth stocks of companies across market-caps and typically invest in US convertibles, US high yield bonds and mortgage-backed securities for fixed-income. AGI also makes alternative investments. They have a strong focus on superior alpha-creation and modern risk management techniques are a primary concern.

AllianzGI US manages client portfolios (directly or through model delivery and wrap fee programs) using traditional and systematic processes across various investment strategies. The firm offers an array of US equity strategies that vary across style and market-cap ranges. Their high yield bond and convertibles strategies employ a fundamental bottom-up process that seeks the early identification of high yield issuers that exhibit the potential for improving fundamental characteristics. AllianzGI US employs rigorous fundamental research and capital structure analysis to construct portfolios that consist of the best companies from a risk/return standpoint. They also offer alternative investment strategies that are designed to achieve absolute return, alpha enhancement and beta hedging.

Schroer Capital manages the Schroer Capital Partners LP, a long/short equity hedge fund. The fund employs a fundamental research approach to select investments in the stocks of US healthcare companies. Schroer Capital has particular expertise in short selling.